{
  "id": 20503416,
  "title": "Denmark’s Commit Biologics secures €54 million Seed funding to advance cancer and autoimmune therapies",
  "url": "https://urgent.news/2026/11/17/denmarks-commit-biologics-secures-54-million-seed-funding-to-advance",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-11-17T09:01:50.000Z",
  "source": {
    "name": "EU-Startups",
    "slug": "eu-startups",
    "url": "https://www.eu-startups.com/2026/11/denmarks-commit-biologics-secures-e54-million-seed-funding-to-advance-cancer-and-autoimmune-therapies/"
  },
  "original_language": "en",
  "account": null,
  "summary": "Copenhagen-based BioTech startup Commit Biologics has raised €54 million ($60 million) in Seed funding to develop new treatments for cancer and autoimmune diseases. The investment will help the Danish company bring its first drug candidate closer to clinical trials. The final close was led by Ackermans & van Haaren, with participation from additional new investors […] The post Denmark’s Commit…",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}